Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies
This concluding post attempts to synthesize contributions to the symposium “From Principles to Practice: Human Rights and Public Health Emergencies”
TRIPS
-
Read more: Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies -
Read more: Non-State Actors and Public Health Emergencies Non-State Actors and Public Health Emergencies
What are the specific legal and ethical implications of involving private actors in health care vis-à-vis public health emergencies?
-
Read more: Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency
Infodemic management must be an integral part of public health emergency prevention, preparedness, response, and recovery.
-
Read more: COVID-19 Showcased Failed Global Cooperation COVID-19 Showcased Failed Global Cooperation
Health emergencies happen: rights protections, solidarity should be central to response.
-
Read more: Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies
In this symposium, experts around the world reflect on the recently issued Principles and Guidelines on Human Rights and Public Health Emergencies.
-
Read more: The European Commission’s New Compulsory Licensing Proposal: A Step Forward? The European Commission’s New Compulsory Licensing Proposal: A Step Forward?
The EU’s effort to establish a Union compulsory license is a step toward harmonizing patent law and creating a more effective single market.
-
Read more: What Happened to the COVID-19 Vaccine Patent Waiver? What Happened to the COVID-19 Vaccine Patent Waiver?
The negotiations leading to the WTO Decision proved once again the inadequacy of the debate over intellectual property rights.
-
Read more: Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’ Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’
COVID-19 vaccine manufacturers refusing to share samples may be the latest example of the tragedy of the “anticommons” in biomedical research.
-
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: The Proposed TRIPS Compromise Risks Setting Several Bad Precedents The Proposed TRIPS Compromise Risks Setting Several Bad Precedents
The proposal introduces precedents that will be used to justify further narrowing of TRIPS flexibilities.
